Royal Bank of Canada Has $39.59 Million Stake in The Cooper Companies, Inc. $COO

Key Points

• Royal Bank of Canada reduced its stake in The Cooper Companies, Inc. by 1.3%, now holding approximately 469,348 shares valued at about $39.59 million.
• Multiple institutional investors increased their holdings in The Cooper Companies during the first quarter, with Mirae Asset Global Investments Co. Ltd. leading with a 15.1% increase.
• Insider purchases include Brian G. Andrews and Gerard H. Warner III, who increased their ownership by 7.38% and 8.60%, respectively, indicating positive insider sentiment.

Royal Bank of Canada reduced its position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 1.3% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 469,348 shares of the medical device company's stock after selling 6,075 shares during the period. Royal Bank of Canada owned about 0.23% of Cooper Companies worth $39,590,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in COO. Twin Tree Management LP lifted its position in shares of Cooper Companies by 669.1% during the first quarter. Twin Tree Management LP now owns 4,553 shares of the medical device company's stock worth $384,000 after purchasing an additional 5,353 shares in the last quarter. Vident Advisory LLC grew its holdings in Cooper Companies by 182.6% during the first quarter. Vident Advisory LLC now owns 15,288 shares of the medical device company's stock valued at $1,290,000 after purchasing an additional 9,878 shares during the period. The Manufacturers Life Insurance Company increased its position in shares of Cooper Companies by 0.9% in the 1st quarter. The Manufacturers Life Insurance Company now owns 867,854 shares of the medical device company's stock valued at $73,203,000 after buying an additional 7,728 shares in the last quarter. GKV Capital Management Co. Inc. bought a new position in shares of Cooper Companies during the 1st quarter valued at about $40,000. Finally, Landscape Capital Management L.L.C. acquired a new position in shares of Cooper Companies in the first quarter valued at approximately $850,000. 24.39% of the stock is owned by institutional investors.

Insiders Place Their Bets

In related news, CEO Albert G. White III bought 10,000 shares of the business's stock in a transaction dated Friday, September 5th. The stock was bought at an average price of $68.39 per share, for a total transaction of $683,900.00. Following the purchase, the chief executive officer owned 226,151 shares in the company, valued at $15,466,466.89. This represents a 4.63% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO Daniel G. Mcbride acquired 3,000 shares of the business's stock in a transaction on Tuesday, September 2nd. The shares were bought at an average price of $65.04 per share, with a total value of $195,120.00. Following the completion of the transaction, the chief operating officer directly owned 63,120 shares of the company's stock, valued at approximately $4,105,324.80. The trade was a 4.99% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last quarter, insiders have purchased 15,975 shares of company stock valued at $1,079,566. 1.98% of the stock is owned by insiders.

Cooper Companies Stock Performance

NASDAQ COO traded up $0.80 on Thursday, hitting $68.46. 1,714,732 shares of the stock were exchanged, compared to its average volume of 3,206,109. The company has a market capitalization of $13.61 billion, a PE ratio of 33.72, a P/E/G ratio of 1.78 and a beta of 0.97. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.12 and a quick ratio of 1.24. The business's fifty day moving average is $71.66 and its 200 day moving average is $76.16. The Cooper Companies, Inc. has a 52 week low of $61.78 and a 52 week high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its quarterly earnings data on Wednesday, August 27th. The medical device company reported $1.10 earnings per share for the quarter, topping the consensus estimate of $1.07 by $0.03. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. The company had revenue of $1.06 billion for the quarter, compared to analyst estimates of $1.06 billion. During the same period in the previous year, the business earned $0.96 EPS. Cooper Companies's revenue for the quarter was up 5.7% compared to the same quarter last year. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. Research analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on COO shares. Wells Fargo & Company lowered their target price on Cooper Companies from $93.00 to $72.00 and set an "overweight" rating for the company in a report on Thursday, August 28th. Wall Street Zen downgraded Cooper Companies from a "buy" rating to a "hold" rating in a research report on Saturday, July 12th. Robert W. Baird lowered their price objective on shares of Cooper Companies from $97.00 to $85.00 and set an "outperform" rating on the stock in a report on Thursday, August 28th. Needham & Company LLC restated a "buy" rating and set a $94.00 target price on shares of Cooper Companies in a report on Thursday, August 28th. Finally, Morgan Stanley set a $76.00 price target on shares of Cooper Companies and gave the company an "equal weight" rating in a research note on Thursday, August 28th. One research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $86.64.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.